Posts

Gate Neurosciences plans Phase II MDD trial with next-g...

The company aims to start the Phase II study of its lead compound zelquistinel i...

Oldest architectural plans detail mysterious desert meg...

The oldest scale plans of human made mega structures are reported in the open ac...

STAT+: FTC widens probe into pharmacy benefit managers ...

The Federal Trade Commission is widening its probe into PBMs and their impact on...

Senators probing largest Medicare Advantage plans over ...

Senators warned the country’s largest Medicare Advantage insurers that they cann...

Study: Giving an antibiotic to household contacts of pe...

In a new trial, providing contacts of people with leprosy with a single dose of ...

STAT+: House panel takes first steps toward reining in ...

A House panel took its first steps toward reining in how hospitals are paid and ...

Federal judges question FDA authority in abortion pill ...

Federal judges questioned the FDA's authority during an appeals court hearing ov...

STAT+: Could an upcoming Supreme Court case make the FD...

The FDA could take longer to write regulations and make decisions if the Supreme...

STAT+: CVS Health to close clinical trial unit two year...

CVS first revealed its clinical trials unit in May 2021, which had a focus on dr...

STAT+: Pharmalittle: FTC suit over Amgen spotlights ‘bu...

The FTC's suit to block Amgen from acquiring Horizon Therapeutics cast a spotlig...

STAT+: PTC Therapeutics’s PKU drug succeeds in trial, b...

Biotech firm PTC Therapeutics said Wednesday that its drug for phenylketonuria, ...

STAT+: A new startup looks to turn the workhorse of gen...

“This is already the way your body fights cancer. We're basically just superchar...

Opinion: How ‘Lessons From the Covid War’ falls short

As with our pandemic response itself, "Lessons from the Covid War" goes wrong mo...

Opinion: Do chatbots have more time to be empathetic th...

Oncologist Jennifer Lycette is doubtful that AI could replace that personal conn...

Opinion: New draft recommendations for mammograms take ...

All patients should have the opportunity to understand mammography’s limitations...

Opinion: Starting breast cancer screening at 40 saved m...

The decision to lower the recommended age for breast cancer screening back to 40...